John S. Lambert

Research interests

Publications

• Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms

  Open Forum Infectious Diseases · 2022 · 10.1093/ofid/ofac060

• Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms

  Open Forum Infectious Diseases · 2022 · 10.1093/ofid/ofac060

• COVID-19’s impact on primary care and related mitigation strategies: A scoping review

  European Journal of General Practice · 2021 · 10.1080/13814788.2021.1946681

• Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa

  BMC Infectious Diseases · 2018 · 10.1186/s12879-018-3087-8

• High rate of unplanned pregnancy in the context of integrated family planning and HIV care services in South Africa

  BMC Health Services Research · 2018 · 10.1186/s12913-018-2942-z

• Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

  Clinical Infectious Diseases · 2010 · https://doi.org/10.1086/656417

• Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration

  AIDS Patient Care and STDs · 2010 · 10.1089/apc.2010.0142

• Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception

  Sexually Transmitted Infections · 2008 · 10.1136/sti.2008.032300

• Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers

  Blood · 2006 · 10.1182/blood-2006-04-015818

• Drug-conjugated monoclonal antibodies for the treatment of cancer

  Current Opinion in Pharmacology · 2005 · 10.1016/j.coph.2005.04.017

• Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold‐Adapted, Administered to Human Immunodeficiency Virus (HIV)–Infected and Non–HIV‐Infected Adults

  The Journal of Infectious Diseases · 2000 · 10.1086/315246

• Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin for Reducing Perinatal HIV Transmission from HIV‐Infected Women with Advanced Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185

  The Journal of Infectious Diseases · 1999 · 10.1086/314637

• Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine

  New England Journal of Medicine · 1999 · 10.1056/nejm199908053410601

• Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12

  Journal of Virology · 1997 · 10.1128/jvi.71.10.7198-7206.1997

• A Survey of Zidovudine Use in Pregnant Women with Human Immunodeficiency Virus Infection

  New England Journal of Medicine · 1992 · 10.1056/nejm199203263261303

• Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical Trial

  The Journal of Infectious Diseases · 1992 · 10.1093/infdis/166.2.244

• 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex

  New England Journal of Medicine · 1990 · 10.1056/nejm199005103221901

Current projects

No projects listed.